Packed Red Blood Cell Transfusion During Cardiac Arrest

Paused · Phase 1

Conditions studied: Cardiac Arrest

In brief

The purpose of this pilot interventional study is to collect preliminary data on administering packed red blood cell (PRBC) during cardiac arrest (CA). The primary objective is to assess the feasibility of PRBC transfusion during cardiac CA to help optimize the methods required to augment cerebral and other vital organ oxygen delivery during cardiopulmonary resuscitation (CPR). The secondary objectives are to assess the effect of PRBC transfusion during prolonged cardiac arrests on cerebral oxygenation, end tidal carbon dioxide (ETCO2), return of spontaneous circulation (ROSC), survival to discharge, biomarkers of neural injury and inflammation, and neurological outcomes at hospital discharge, 30 days post-CA, and 90 days post-CA.

Key facts

Study ID

NCT06462027

Run by

NYU Langone Health

People needed

30

Starts

2026-06-01

Expected to finish

2027-09-01

Last updated by the study team

2026-04-09

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients, age ≥18 and <85 years
• Experience prolonged, non-trauma-related in-hospital cardiac arrest, defined by cessation of heartbeat and respiration requiring CPR for at least 10 minutes

You may not qualify if…

• Age <18 years old
• Age > 85 years old
• Patients with DNR/DNI orders (Do Not Resuscitate/Do Not Intubate)
• Patients admitted to the hospital with a cardiac arrest arising from trauma
• Patients who achieve return of spontaneous circulation within 10 minutes of CPR
• Inability to start study product administration within 20 minutes of cardiac arrest onset
• Prisoners
• Women who are known to be pregnant
• Patients with a history of RBC antibodies or positive antibody screen prior to enrollment in the study, unless previously cross-matched units are available for transfusion.
• Patients with ultrasound evidence of right ventricular dilatation at time of CA
• Patients with known prior objection to receipt of blood products.
• Patients for whom administration of additional fluid volume is contraindicated (as determined by physician responsible for care)
• Physician objection based on concern that intervention would interfere with patient care plan

Where it is running

• NYU Langone Health — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.